Developing a novel patient reported outcomes measure for prostate cancer patients receiving radionuclide therapy. Gudenkauf LM, Chavez M, Maconi ML, Geiss C, et al. J Nucl Med 2023 Jan 12:jnumed.122.264946. doi: 10.2967/jnumed.122.264946.

Read + Share

Amedeo Smart

Independent Medical Education

Gudenkauf LM, Chavez M, Maconi ML, Geiss C, et al. Developing a novel patient reported outcomes measure for prostate cancer patients receiving radionuclide therapy. J Nucl Med 2023 Jan 12:jnumed.122.264946. doi: 10.2967/jnumed.122.264946.
PMID: 36635088